세계의 마이크로서저리 및 슈퍼 마이크로서저리 시장 : 최종사용자별, 장비별, 시술별, 지역별 - 예측 분석(-2032년)

Global Microsurgery & Super-Microsurgery Market Research by End User (Hospitals, Ambulatory Surgical Centers, Others), by Equipment (Operating Microscopes, Super Micro Sutures, Micro Forceps, Microsurgery Needle Holder, Surgical Scalpel/ Ophthalmic Knives, Others), by Procedure (Orthopedic Microsurgery, Ophthalmic Microsurgery, Plastic & Reconstructive Microsurgery, ENT Microsurgery, Neurological Microsurgery, Gynecological & Urological Microsurgery, Others), by Region (North America, Europe, Asia Pacific, Rest of the World) Forecast Analysis till 2032

Industry Overview

The market for microsurgery and super-microsurgery was valued at USD 1,961.54 million in 2022 and is expected to reach USD 3,783.66 million in 2032, growing at a Compound Annual Growth Rate (CAGR) of 6.07% between 2023 and 2032.

The aging population and the rise in surgical operations are the main drivers of global microsurgery and super-microsurgery market. Innovations in research and development, along with a surge in transplant operations, have increased the demand for precise surgical methods, particularly in orthopedic and reconstructive fields. Chronic illnesses and age-related health issues further accelerate the need for high-success microsurgical techniques.

However, the market encounters barriers such as surgical complications, including infections, delayed wound healing, nerve damage, visible scarring, anesthesia-related problems, and the possible requirement for follow-up surgeries.

On the positive side, the market presents substantial opportunities due to the rise in lifestyle-related disorders and continued technological improvements. Government approvals and the development of new tools like advanced ophthalmic microscopes are enhancing procedural accuracy. As lifestyle diseases increase among both older and younger demographics, these innovations will drive market growth by offering safer, more effective microsurgical options.

Industry Segmentations

Global microsurgery and super microsurgery market is segmented by the end user, includes hospitals and ambulatory surgical centers and others.

In terms of equipment type, global microsurgery and super microsurgery market is categorized into operating microscopes, super micro sutures, micro forceps, microsurgery needle holder, surgical scalpel/ ophthalmic knives, and others.

Based on the procedure category, global microsurgery and super microsurgery market has been segmented into Orthopedic Microsurgery, Ophthalmic Microsurgery, Plastic & Reconstructive Microsurgery, ENT Microsurgery, Neurological Microsurgery, Gynecological & Urological Microsurgery.

North America, Asia Pacific, Europe, and rest of the world are the part of regional types of global market.

Regional Analysis

Global microsurgery and super-microsurgery market continues to evolve with distinct trends across regions. North America has experienced substantial growth, largely due to rapid advancements in medical technology and a growing inclination toward minimally invasive surgical techniques used in various specialties.

In Europe, the market has matured significantly, supported by a surge in medical innovations, an aging population, and a rise in chronic illnesses. Microsurgical techniques involving precision tools and microscopes, along with highly specialized super-microsurgery methods, are now widely utilized in reconstructive surgery, orthopedics, ophthalmology, and plastic surgery.

The Asia Pacific region is showing impressive momentum, spurred by active investment in research and development. Top-tier medical centers and universities are at the cutting edge of refining and developing complex surgical procedures that enhance accuracy and treatment outcomes.

In contrast, the market in the Middle East, Africa, and Latin America is expanding but still faces hurdles. Although these regions are recognizing the potential of advanced microsurgical techniques, progress is slowed by the lack of skilled professionals, expensive medical equipment, and gaps in healthcare infrastructure. These challenges limit accessibility and prevent widespread adoption, even as interest in these advanced procedures grows steadily.

Key Players

Olympus Corporation, Kontron AG, B. Braun SE, Zimmer Biomet, Carl Zeiss Meditec, Global Surgical Corporation, Karl Kaps GmbH & Co. KG, Medtronic, Smith+Nephew, Topcon Corporation, Stille AB, Stryker, BVI, Johnson & Johnson Services Inc, Haag-Streit Group, KLS Martin Group, Microsurgery Instruments Inc, Peter Lazic GmbH, Alco Inc, Synovis Micro Companies Alliance Inc. are the key companies of global microsurgery and super microsurgery industry.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

• 2.1 DEFINITION
• 2.2 SCOPE OF THE STUDY
• 2.3 RESEARCH OBJECTIVE
• 2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

• 3.1 OVERVIEW
• 3.2 DATA FLOW
  • 3.2.1 DATA MINING PROCESS
• 3.3 PURCHASED DATABASE:
• 3.4 SECONDARY SOURCES:
  • 3.4.1 SECONDARY RESEARCH DATA FLOW:
• 3.5 PRIMARY RESEARCH:
  • 3.5.1 PRIMARY RESEARCH DATA FLOW:
  • 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
  • 3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE
• 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
  • 3.6.1 REVENUE ANALYSIS APPROACH
• 3.7 DATA FORECASTING
  • 3.7.1 DATA FORECASTING TECHNIQUE
• 3.8 DATA END USERLING
  • 3.8.1 MICROECONOMIC FACTOR ANALYSIS:
  • 3.8.2 DATA END USERLING:
• 3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

• 4.1 INTRODUCTION
• 4.2 DRIVERS
  • 4.2.1 GROWING NUMBER OF SURGICAL PROCEDURES
  • 4.2.2 INCREASING NUMBER OF GERIATRIC POPULATION
• 4.3 RESTRAINTS
  • 4.3.1 COMPLICATIONS AND RISKS DUE TO THE PROCEDURE
• 4.4 OPPORTUNITY
  • 4.4.1 INCREASING INCIDENCE OF LIFESTYLE DISORDERS AND GROWING TECHNOLOGICAL ADVANCEMENTS

5 MARKET FACTOR ANALYSIS

• 5.1 VALUE CHAIN ANALYSIS
  • 5.1.1 R&D
  • 5.1.2 MANUFACTURING
  • 5.1.3 DISTRIBUTION AND SALES
  • 5.1.4 POST-SALES MONITORING
• 5.2 PORTER'S FIVE FORCES MODEL
  • 5.2.1 THREAT OF NEW ENTRANTS
  • 5.2.2 BARGAINING POWER OF SUPPLIERS
  • 5.2.3 THREAT OF SUBSTITUTES
  • 5.2.4 BARGAINING POWER OF BUYERS
  • 5.2.5 INTENSITY OF RIVALRY
• 5.3 IMPACT OF COVID-19 ON THE GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET
  • 5.3.1 IMPACT ON SUPPLY CHAIN
  • 5.3.2 IMPACT ON KEY PLAYERS
  • 5.3.3 IMPACT ON DEMAND AND SUPPLY

6 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT

• 6.1 OVERVIEW
• 6.2 OPERATING MICROSCOPES
• 6.3 SUPER MICRO SUTURES
• 6.4 MICRO FORCEPS
• 6.5 MICROSURGERY NEEDLE HOLDER
• 6.6 SURGICAL SCALPEL/ OPHTHALMIC KNIVES
• 6.7 OTHERS

7 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE

• 7.1 OVERVIEW
• 7.2 ORTHOPEDIC MICROSURGERY
• 7.3 OPHTHALMIC MICROSURGERY
• 7.4 PLASTIC & RECONSTRUCTIVE MICROSURGERY
• 7.5 ENT MICROSURGERY
• 7.6 NEUROLOGICAL MICROSURGERY
• 7.7 GYNECOLOGICAL & UROLOGICAL MICROSURGERY
• 7.8 OTHERS

8 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER

• 8.1 OVERVIEW
• 8.2 HOSPITALS
• 8.3 AMBULATORY SURGICAL CENTERS
• 8.4 OTHERS

9 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY REGION

• 9.1 OVERVIEW
• 9.2 NORTH AMERICA
  • 9.2.1 US
  • 9.2.2 CANADA
• 9.3 EUROPE
  • 9.3.1 GERMANY
  • 9.3.2 FRANCE
  • 9.3.3 UK
  • 9.3.4 ITALY
  • 9.3.5 SPAIN
  • 9.3.6 REST OF EUROPE
• 9.4 ASIA-PACIFIC
  • 9.4.1 CHINA
  • 9.4.2 JAPAN
  • 9.4.3 INDIA
  • 9.4.4 AUSTRALIA
  • 9.4.5 SOUTH KOREA
  • 9.4.6 REST OF ASIA-PACIFIC
• 9.5 REST OF WORLD
  • 9.5.1 MIDDLE EAST
  • 9.5.2 SOUTH AMERICA

10 COMPETITIVE LANDSCAPE

• 10.1 INTRODUCTION
• 10.2 MARKET SHARE ANALYSIS, 2022
• 10.3 COMPETITOR DASHBOARD
• 10.4 PUBLIC PLAYERS STOCK SUMMARY
• 10.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
• 10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
  • 10.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL

1 0.6.2 ACQUISITION/INVESTMENT/EXPANSION

• 10.7 COMPETITOR PRODUCT ANALYSIS
  • 10.7.1 OPERATING MICROSCOPES
  • 10.7.2 MICRO FORCEPS
  • 10.7.3 SUPER MICRO SUTURES
  • 10.7.4 MICROSURGERY NEEDLE HOLDER
  • 10.7.5 SURGICAL SCALPEL/ OPHTHALMIC KNIVES

11 COMPANY PROFILES

• 11.1 KONTRON AG
  • 11.1.1 COMPANY OVERVIEW
  • 11.1.2 FINANCIAL OVERVIEW
  • 11.1.3 PRODUCTS OFFERED
  • 11.1.4 KEY DEVELOPMENTS
  • 11.1.5 KEY STRATEGIES
• 11.2 CARL ZEISS MEDITEC AG
  • 11.2.1 COMPANY OVERVIEW
  • 11.2.2 FINANCIAL OVERVIEW
  • 11.2.3 PRODUCTS OFFERED
  • 11.2.4 KEY DEVELOPMENTS
  • 11.2.5 SWOT ANALYSIS
  • 11.2.6 KEY STRATEGIES
• 11.3 GLOBAL SURGICAL CORPORATION
  • 11.3.1 COMPANY OVERVIEW
  • 11.3.2 FINANCIAL OVERVIEW
  • 11.3.3 PRODUCTS OFFERED
  • 11.3.4 KEY DEVELOPMENTS
  • 11.3.5 KEY STRATEGIES
• 11.4 KARL KAPS GMBH & CO. KG
  • 11.4.1 COMPANY OVERVIEW
  • 11.4.2 FINANCIAL OVERVIEW
  • 11.4.3 PRODUCTS OFFERED
  • 11.4.4 KEY DEVELOPMENTS
  • 11.4.5 KEY STRATEGIES
• 11.5 MEDTRONIC
  • 11.5.1 COMPANY OVERVIEW
  • 11.5.2 FINANCIAL OVERVIEW
  • 11.5.3 PRODUCTS OFFERED
  • 11.5.4 KEY DEVELOPMENTS
  • 11.5.5 SWOT ANALYSIS
  • 11.5.6 KEY STRATEGIES
• 11.6 OLYMPUS CORPORATION
  • 11.6.1 COMPANY OVERVIEW
  • 11.6.2 FINANCIAL OVERVIEW
  • 11.6.3 PRODUCTS OFFERED
  • 11.6.4 KEY DEVELOPMENTS
  • 11.6.5 KEY STRATEGIES
• 11.7 SMITH+NEPHEW
  • 11.7.1 COMPANY OVERVIEW
  • 11.7.2 FINANCIAL OVERVIEW
  • 11.7.3 PRODUCTS OFFERED
  • 11.7.4 KEY DEVELOPMENTS
  • 11.7.5 KEY STRATEGIES
• 11.8 ZIMMER BIOMET
  • 11.8.1 COMPANY OVERVIEW
  • 11.8.2 FINANCIAL OVERVIEW
  • 11.8.3 PRODUCTS OFFERED
  • 11.8.4 KEY DEVELOPMENTS
  • 11.8.5 SWOT ANALYSIS
  • 11.8.6 KEY STRATEGIES
• 11.9 TOPCON CORPORATION
  • 11.9.1 COMPANY OVERVIEW
  • 11.9.2 FINANCIAL OVERVIEW
  • 11.9.3 PRODUCTS OFFERED
  • 11.9.4 KEY DEVELOPMENTS
  • 11.9.5 KEY STRATEGIES
• 11.10 STILLE AB
  • 11.10.1 COMPANY OVERVIEW
  • 11.10.2 FINANCIAL OVERVIEW
  • 11.10.3 PRODUCTS OFFERED
  • 11.10.4 KEY DEVELOPMENTS

1 1.10.5 KEY STRATEGIES

• 11.11 B. BRAUN SE
  • 11.11.1 COMPANY OVERVIEW
  • 11.11.2 FINANCIAL OVERVIEW
  • 11.11.3 PRODUCT OFFERED
  • 11.11.4 KEY DEVELOPMENTS
  • 11.11.5 SWOT ANALYSIS
  • 11.11.6 KEY STRATEGY
• 11.12 STRYKER
  • 11.12.1 COMPANY OVERVIEW
  • 11.12.2 FINANCIAL OVERVIEW
  • 11.12.3 PRODUCTS OFFERED
  • 11.12.4 KEY DEVELOPMENTS
  • 11.12.5 KEY STRATEGIES
• 11.13 BVI
  • 11.13.1 COMPANY OVERVIEW
  • 11.13.2 FINANCIAL OVERVIEW
  • 11.13.3 PRODUCTS OFFERED
  • 11.13.4 KEY DEVELOPMENTS
  • 11.13.5 KEY STRATEGY
• 11.14 JOHNSON & JOHNSON SERVICES INC
  • 11.14.1 COMPANY OVERVIEW
  • 11.14.2 FINANCIAL OVERVIEW
  • 11.14.3 PRODUCTS OFFERED
  • 11.14.4 KEY DEVELOPMENTS
  • 11.14.5 SWOT ANALYSIS
  • 11.14.6 KEY STRATEGIES
• 11.15 HAAG-STREIT GROUP
  • 11.15.1 COMPANY OVERVIEW
  • 11.15.2 FINANCIAL OVERVIEW
  • 11.15.3 PRODUCTSOFFERED
  • 11.15.4 KEY DEVELOPMENTS
  • 11.15.5 KEY STRATEGIES
• 11.16 KLS MARTIN GROUP
  • 11.16.1 COMPANY OVERVIEW
  • 11.16.2 FINANCIAL OVERVIEW
  • 11.16.3 PRODUCT OFFERED
  • 11.16.4 KEY DEVELOPMENTS
  • 11.16.5 KEY STRATEGIES
• 11.17 MICROSURGERY INSTRUMENTS, INC
  • 11.17.1 COMPANY OVERVIEW
  • 11.17.2 FINANCIAL OVERVIEW
  • 11.17.3 PRODUCTS OFFERED
  • 11.17.4 KEY DEVELOPMENTS
  • 11.17.5 KEY STRATEGIES
• 11.18 PETER LAZIC GMBH
  • 11.18.1 COMPANY OVERVIEW
  • 11.18.2 FINANCIAL OVERVIEW
  • 11.18.3 PRODUCT OFFERED
  • 11.18.4 KEY DEVELOPMENTS
  • 11.18.5 KEY STRATEGIES
• 11.19 ALCON INC
  • 11.19.1 COMPANY OVERVIEW
  • 11.19.2 FINANCIAL OVERVIEW
  • 11.19.3 PRODUCT OFFERED
  • 11.19.4 KEY DEVELOPMENTS
  • 11.19.5 KEY STRATEGIES
• 11.20 SYNOVIS MICRO COMPANIES ALLIANCE, INC
  • 11.20.1 COMPANY OVERVIEW
  • 11.20.2 FINANCIAL OVERVIEW
  • 11.20.3 PRODUCT OFFERED
  • 11.20.4 KEY DEVELOPMENTS
  • 11.20.5 KEY STRATEGIES

12 DATA CITATIONS